AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates

18d ago, source: Zacks.com on MSN

AngioDynamics, Inc. ANGO reported an adjusted loss per share of 16 cents for third-quarter fiscal 2024, wider than the ...

AngioDynamics (ANGO) Settles Patent Litigations With BD

21d ago, source: Zacks.com on MSN

AngioDynamics, Inc. ANGO recently announced that it has entered into a settlement agreement with Becton, Dickinson and ...

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

23d ago, source: Yahoo Finance

LATHAM, N.Y., April 01, 2024--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s ...

AngioDynamics Inc. hosts conference call for investors

19d ago, source: Business Insider

The company, AngioDynamics Inc., is set to host investors and clients on a conference call on 4/4/2024 2:48:23 PM. The call comes after the company's earnings, which are set to be announced on 4/4 ...

AngioDynamics Settles All Patent Litigation With C.R. Bard

22d ago, source: Nasdaq

(RTTNews) - AngioDynamics Inc. (ANGO) said that it has reached a settlement agreement with Becton, Dickinson and Company or "BD" to resolve all outstanding patent litigation with C.R. Bard Inc ...

AngioDynamics: Fiscal Q3 Earnings Snapshot

19d ago, source: The Washington Post

LATHAM, N.Y. — LATHAM, N.Y. — AngioDynamics Inc. (ANGO) on Thursday reported a loss of $190.4 million in its fiscal third quarter. On a per-share basis, the Latham, New York-based company said ...

AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE

19d ago, source: Stockhouse

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer ...

AngioDynamics Q3 Loss Sharply Widens; Slashes FY24 Outlook

19d ago, source: Business Insider

(RTTNews) - While reporting financial results for the third quarter on Thursday, medical devices company AngioDynamics, Inc. (ANGO) slashed its adjusted loss and net sales guidance for the full ...

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

21d ago, source: Morningstar

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc. AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring ...

AngioDynamics Receives 510(k) Clearance for AlphaVac F18⁸⁵ System in Treatment of PE

19d ago, source: Nasdaq

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system ...